SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
The U.S. Supreme Court has decided not to review a lower court’s decision to invalidate one of Sequenom’s patents.
Health Center Partners of Southern California (HCP) will receive $2.6 million in federal grants to expand oral health care services, the organization announced Monday.
A jury ruled that Oceanside’s Tri-City Medical Center should pay Carlsbad’s Medical Acquisition Company Inc. (MAC) $19.7 million in a dispute over a medical office building that’s sat vacant since 2013.
Ardea Biosciences, a local biotech sold to Big Pharma for big bucks, will lay off up to 145 employees in San Diego and eventually close down.
Leading BioSciences Inc. has appointed Greg Doyle as its new chief executive officer.
BIOTECH: Goal Is Smaller And Cheaper Disposable Monitors
Medtronic has joined with Qualcomm Life Inc., a wholly-owned subsidiary of San Diego-based Qualcomm Inc., to bring Qualcomm’s wireless technology to Medtronic’s diabetes devices — even though a competing technology may beat them to market.
Medtech giant Illumina Inc. dedicated a research and development building on its campus to its longtime CEO Jay Flatley.
Medical device firm Dexcom Inc. is joining the ranks of San Diego companies that are building manufacturing operations outside the state.
Reflexion Health, a San Diego digital health company, has landed $18 million in a Series B round led by inside investors, the company announced Wednesday.
Mark Gergen, the executive vice president and chief operations officer at Mirati Theraputics Inc., is stepping down, the company announced Wednesday.
A San Diego medtech giant is one of the “smartest” companies out there, according to MIT Technology Review, which Tuesday released its annual list of 50 companies that have created new markets or taken risks to disrupt an existing marketplace.
Local medical device maker Dexcom Inc. is building a new manufacturing facility near Phoenix, the company announced Monday.
Regulus Therapeutics Inc. has entered into a $30 million loan and security agreement with Oxford Finance LLC, the company announced Monday. The infusion of cash gives the local biopharma the runway needed to progress its products through the clinic.
Calbiotech Meets the Challenges of Moving and of Moving Up in the Life Science World
It’s a good sign when a company has to move into a larger space. Calbiotech Inc., which manufactures life science products, outgrew 11,000 square feet in Spring Valley and recently traded up to 22,000 square feet in El Cajon. It also recently hired six employees, giving it a headcount of 45.